news
Bristol-Myers Squibb to present new data on ORENCIA®
14 May 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced that the company will present 18 abstracts on ORENCIA®...
List view / Grid view
Bristol-Myers Squibb Company
news
Bristol-Myers Squibb to present at Bank of America Merrill Lynch Health Care Conference
10 May 2012 | By Bristol-Myers Squibb Company
Doug Manion to will make a formal presentation...
news
FORXIGA (dapagliflozin) receives positive CHMP opinion in the EU for the treatment of type 2 diabetes
23 April 2012 | By AstraZeneca
In combination with other glucose-lowering medicinal products including insulin...
news
FORXIGA® (dapagliflozin) Receives Positive CHMP Opinion in the European Union for the Treatment of Type 2 Diabetes
20 April 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and AstraZeneca announced that the CHMP of the EMA has recommended approval of FORXIGA® (dapagliflozin) tablets...
news
Agreement to develop diagnostic assays for Alzheimer’s disease
28 March 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Meso Scale Discovery have entered an agreement...
news
U.S. FDA extends action date for ELIQUIS® (apixaban) by three months
29 February 2012 | By Pfizer
The U.S. FDA has extended the action date by three months for the NDA for Eliquis® (apixaban)...
news
Bristol-Myers Squibb and Duke Translational Medicine Institute form strategic relationship to broaden interactions
28 February 2012 | By Bristol-Myers Squibb Company
First project will be to develop and implement protocol for Phase II study in IPF...
article
Near Infrared supplement 2012
In this Near Infrared supplement: Understanding external factor influences and the right use of chemometrics; Recent advances in spectroscopic measurements applied to pharmaceutical testing; Discover what vendor companies are discussing in our Near Infrared Spectroscopy Leaders Roundtable...
news
Bristol-Myers Squibb Foundation announces grants focused on prevention, diagnosis & care of Hepatitis B and Hepatitis C in Asia
18 February 2012 | By Bristol-Myers Squibb
Three new grants awarded...
news
Bristol-Myers Squibb completes acquisition of Inhibitex, Inc.
13 February 2012 | By Bristol-Myers Squibb Company
Completion of the tender offer by Bristol-Myers for all of the outstanding shares of common stock of Inhibitex, Inc...
news
Sanofi and Bristol-Myers Squibb collect damages in Plavix patent litigation with Apotex
8 February 2012 | By Bristol-Myers Squibb Company
Apotex has made payment to Sanofi & Bristol-Myers Squibb...
news
Expiration of the Hart-Scott-Rodino waiting period for acquisition of Inhibitex, Inc.
3 February 2012 | By Bristol-Myers Squibb Company
Expiration of the HSR waiting period for acquisition of Inhibitex, Inc...
news
Bristol-Myers Squibb names Gerald L. Storch to Board of Directors
24 January 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced that its Board of Directors has elected Gerald L. Storch to the Board...
news
Bristol-Myers Squibb announces charitable donation of $6.9 million to support cancer patients
19 January 2012 | By Bristol-Myers Squibb Company
Donation of $6.9 million in 2011 to support the HealthWell Foundation...
news
AstraZeneca and Bristol-Myers Squibb receive complete response letter from US FDA for dapagliflozin
19 January 2012 | By AstraZeneca
The FDA has issued a complete response letter regarding dapagliflozin...
